0001209191-21-064740.txt : 20211116
0001209191-21-064740.hdr.sgml : 20211116
20211116160733
ACCESSION NUMBER: 0001209191-21-064740
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211115
FILED AS OF DATE: 20211116
DATE AS OF CHANGE: 20211116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 211416105
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Patient Officer
Common Stock
2021-11-15
4
S
0
21
186.78
D
31958
D
Common Stock
2021-11-15
4
S
0
30
187.48
D
31928
D
Common Stock
882
I
401(k)
Common Stock
15573
I
Held in Trust
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $186.78 (range $186.22 to $187.19).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $187.48 (range $187.24 to $187.85).
/s/ Sabrina Yohai, Attorney-in-Fact
2021-11-16